Cecilia Poli

La inmunología marca el rumbo de la medicina del futuro en el 46.º Congreso de la SEI immedicohospitalario.es/noticia/56018/… vía @IMMedicoHosp

How I treat: Jennifer W. Leiding, Michael D. Keller and colleagues present their practical guide to diagnosis and treatment of chronic granulomatous disease, including the first comprehensive clinical protocol for treatment of CGD. hubs.la/Q04clwT00 #InbornErrorsOfImmunity

We’re excited to welcome Dr. Luigi D. Notarangelo for our next JMF Speaker Series as he presents: “Primary Immunodeficiencies: A Continuously Evolving Story.” From groundbreaking research to the future of diagnosis and treatment, this session will explore how the story of PI continues to unfold. Moderated by Dr. Lisa Forbes Satter, this is a conversation you won’t want to miss. ✅ Free registration available now – click here: bit.ly/4medOFH to sign up!

This is a thorough, critical, and superb Review of a complex and controversial human B cell subset, the famous "ABC" -- a must-read !👇 Human CD21loT-bet+ B cells: Not as easy as “ABC”! rupress.org/jhi/article/2/…

A thoughtful consensus on how to manage patients with CGD: How I treat chronic granulomatous disease rupress.org/jhi/article/2/…

New review by @stutangye provides an overview of the discoveries, origins, and complexities of CD21ˡᵒ B cells, and how studying inborn errors of immunity can provide a unique window to understand the molecular requirements for generating these cells. hubs.la/Q04clJ340

Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohorts rupress.org/jhi/article/2/…

Gervais, Trespidi, Ferrari, Rovida, Cobat, Zhang, Casanova, Borghesi et al. show that, in 13 European, Middle-Eastern, and American cohorts, pre-existing autoantibodies neutralizing type I IFNs are causal for WNV encephalitis in about 40% of patients. hubs.la/Q046JZ5J0

El Centro de Interés Nacional SENTINET se encuentra en la búsqueda de investigadores postdoctorales e investigadores jóvenes para sumarse a su equipo y trabajar en diferentes temáticas de enfermedades infecciosas emergentes. ➡️ Más información: investigacion.udd.cl/2026/03/16/con…

Again, news about human inherited DBR1 deficiency: Defects in intron recycling suppress the antiviral response via a mechanism of intronic endogenous dsRNA rupress.org/jem/article-ab…

1/ Which human infectious disease is best understood in 2026? West Nile virus encephalitis, with 40% of cases attributed causally and mechanistically to auto-Abs neutralizing type I IFNs. doi.org/10.70962/jhi.2…

🔔 We're pleased to share the abstracts from the Latin American Society for Immunodeficiencies Meeting 2025 @LASIDimmuno, which took place October 15–18, in Buenos Aires. Explore the latest advancements and insights in immunodeficiencies 👉 hubs.la/Q03YXY4P0

Ultimate precision medicine! Delighted to have played a small part to ensure our patient from @BCChildrensHosp was able to receive this remarkable curative treatment. Kudos to @ElieHaddad55 for launching this trial in Canada. @NEJM @UBCNews @BCCHF @GenomeBC @GenomeCanada

This Rare Disease Day 🧬, we share how GREGoR 🫛 bridges the diagnostic gap in rare disease by developing and applying cutting-edge technologies to discover the causes of unsolved genetic disorders and sharing data to accelerate discovery. 🎯 #GREGoR #NIHResearch #RareDisease

One year after baby KJ Muldoon became the first patient to receive a personalized gene therapy, the @ChildrensPhila @UofPenn team behind the treatment now look to create a scalable pathway for more patients to receive customized gene therapies. Learn more: ms.spr.ly/6011Qbync

Latest from us👇🏼 😀 #fibrosis #interferon type I #apoptosis #woundhealing #ISG15deficiency

🎥 JHI’s Editor-in-Chief Jean-Laurent Casanova shares the vision behind JHI and what sets the journal apart in the rapidly evolving field of human immunity. Watch the full video and learn more about publishing in JHI here 👉 hubs.la/Q041StsR0

The early history of the ESID registry rupress.org/jhi/article/2/…

Despite his body struggling beneath the surface, Jeffrey Modell never let #PrimaryImmunodeficiency lead his life. He continued to embrace life with optimism and high spirits. Inspired by his strength, Vicki and Fred carried that same mindset forward, turning a tragedy into action and purpose. Jeffrey remains as a constant reminder to shine our light even in the face of hardships✨ To learn more about Jeffrey and see his sparkle, watch our documentary here: bit.ly/4rf29I1 #PIAwareness #RareDiseaseAwareness

Latest from us. @columbiaMed @KidsAtColumbia Dr Akalu et al. report on novel variants leading to TBK1 deficiency , resulting in autoinflammation but also in some cases viral diseases. doi.org/10.70962/jhi.2…